The Leadership Team at Comanche Biopharma is responsible for setting the strategic direction and overseeing the execution of the company’s mission to develop siRNA medicine for preterm preeclampsia. This includes guiding clinical trials, product development, commercial planning, and operational efficiencies, ensuring that all initiatives are evidence-based and focused on delivering safe, effective, and affordable therapies for women and their babies facing life-threatening pregnancy complications.
View all